Dennis A. Revicki, PhD
- 6Articles
- 20.4KReads
- 1997–2016Active
- 41Collaborators
- 319Citations
About
Dennis A. Revicki, PhD, has published extensively on clinical and pharmacoeconomic aspects of psychiatric disorders, including major depressive disorder, suicidality, bipolar disorder, and schizophrenia/schizoaffective disorders. His work addresses the reliability and validity of assessment scales, drug safety concerns related to suicidality, and comparative evaluations of treatment outcomes and cost-effectiveness. Revicki’s research includes studies on specific medications such as divalproex sodium, olanzapine, and clozapine. His publications span from 1997 to 2016 in peer-reviewed journals associated with Psychiatrist.com.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
